Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
03/2012
03/06/2012CA2406720C Nitroaromatic solubilizer for nitroxyls in aromatic solvents
03/01/2012WO2012026897A1 A process for the preparation of imatinib base
03/01/2012WO2012025587A1 Process for the manufacture of tmhq
03/01/2012WO2012025450A1 Phenylamidines having a high fungicidal activity and use thereof
03/01/2012WO2012025155A1 Hydroxamate-based inhibitors of deacetylases
03/01/2012US20120052019 Certain chemical entities, compositions, and methods
02/2012
02/29/2012EP2421838A2 Arylsulfonamide ccr3 antagonists
02/29/2012EP2421830A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
02/29/2012EP2421829A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
02/29/2012EP2421375A2 Chemical and biological agents for the control of molluscs
02/29/2012CN102365341A Base-generating agent, photosensitive resin composition, patterning material comprising the photosensitive resin composition, patterning method and article using the photosensitive resin composition
02/28/2012US8124799 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
02/28/2012US8124630 ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
02/28/2012US8124627 Biphenyl compounds useful as muscarinic receptor antagonists
02/28/2012US8124365 Using erastin as therapeutic agent in treatment of cell proliferative disorders associated with mutation in ras gene
02/28/2012US8123982 Sulfur based corrosion inhibitors
02/28/2012CA2436016C Stable ethylene inhibiting compounds and methods for their preparation
02/28/2012CA2333951C Method for treating neurodegenerative disorders
02/23/2012US20120046293 Renin inhibitors
02/23/2012US20120046292 Diacylethylenediamine compound
02/23/2012US20120046291 Extended Triterpene Derivatives
02/23/2012US20120046288 Hydrazonamide Compounds That Modulate Hsp90 Activity
02/23/2012US20120046276 Tuberculosis treatment using pleuromutilin derivatives
02/23/2012US20120046247 1,5-diphenyl-penta-1,4-dien-3-one compounds
02/23/2012US20120045648 Process for the preparation of lasofoxifene tartrate
02/23/2012US20120045448 Trp-p8 active compounds and therapeutic treatment methods
02/22/2012EP2419413A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
02/22/2012EP2234992B1 Piperazine derivatives and their use as leptin receptor modulators
02/22/2012EP0986384B1 Inhibitors of protein isoprenyl transferases
02/22/2012CN102361896A Photoresist composition
02/22/2012CN101088993B Nmmo的蒸发方法 Nmmo evaporation method
02/21/2012US8119664 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
02/21/2012US8119642 Structurally rigid dopamine D3 receptor selective ligands and process for making them
02/21/2012US8119641 1H-furo[3,2-C]pyrazole compounds useful as kinase inhibitors
02/21/2012US8119623 Pyrrolidin-2-ones
02/21/2012CA2508845C Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
02/21/2012CA2508618C Tetrahydro-naphthalene derivatives
02/21/2012CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
02/16/2012WO2012020130A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120041001 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
02/16/2012CA2806643A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/15/2012EP2417101A1 Indane derivatives
02/15/2012EP1999099B1 Process for preparing an amine
02/15/2012EP1963296B1 Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates
02/15/2012EP1755572B1 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators
02/15/2012EP1735268B1 Opioid receptor antagonists
02/15/2012CN102351812A Methanesulfonic acid cinepazide crystal form III and preparation method thereof
02/15/2012CN102351811A Ester derivative of rupestonic acid, and preparation method and purpose thereof
02/15/2012CN102351810A Resolution method of levocetirizine chiral intermediates
02/15/2012CN102351807A Dibenzyl-1,3-oxazolidine-2-ketone compound and preparation method and application thereof
02/15/2012CN102351621A Method for preparing N-sulfonyl amidine
02/15/2012CN101405254B 制备胺的方法 Amine was prepared
02/14/2012US8115027 NPY Y5 antagonist
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114880 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid MTP inhibiting compounds
02/14/2012US8114866 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme
02/09/2012WO2012017166A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
02/09/2012WO2012017027A1 Acid addition salts of the 2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]-(methyl)amino]ethoxy]-n-methyl-n-[3-(4-methylpiperazin-1-yl)cyclohexyl] acetamide and the use thereof as bradykinin b1 receptor antagonists
02/09/2012US20120035176 Analogs of 3-o-acetyl-11-keto-beta-boswellic acid
02/09/2012CA2807078A1 Acid addition salts of the 2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]-(methyl)amino]ethoxy]-n-methyl-n-[3-(4-methylpiperazin-1-yl)cyclohexyl] acetamide and the use thereof asbradykinin b1 receptor antagonists
02/09/2012CA2805206A1 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
02/08/2012EP2415760A2 CCR-9 antagonists
02/08/2012CN101522650B 通过蒸馏连续分离含有吗啉(mo)、单氨基二甘醇(adg)、氨和水的混合物的方法 The method of continuously separating by distillation containing morpholine (mo), the mixture of diethylene glycol mono-amino (adg), ammonia and water in the
02/08/2012CN101376637B 高立方烷二酰胺类化合物及其应用 High cubane diamide compound classes and their applications
02/07/2012US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
02/07/2012US8110595 Ureas and their use in the treatment of heart failure
02/07/2012US8110567 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
02/07/2012CA2529269C Improved pharmaceutical drug candidates and methods for preparation thereof
02/02/2012WO2012016217A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012WO2012015999A2 Process for the preparation of imatinib mesylate
02/02/2012US20120028249 Anthraquinone based near ir emitting compounds and uses thereof
02/02/2012CA2806341A1 Ampk-activating heterocyclic compounds and methods for using the same
02/01/2012EP2411430A1 Photoresist composition
02/01/2012EP2212287B1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
02/01/2012EP2132174B1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
02/01/2012CN102336724A Novel cinepazide salt and its preparation method, and pharmaceutical composition based on cinepazide salt
02/01/2012CN102336723A Preparation method of L-chloperastine fendizoic acid
02/01/2012CN102336679A 7-substituted tetracycline compounds
02/01/2012CN101516862B 高纯度季铵盐的制造方法 The method of producing high-purity quaternary ammonium salt
02/01/2012CN101124213B 磺酰氨基环状衍生物及其应用 Sulphonamido cyclic derivatives and its application
01/2012
01/31/2012US8106225 Catalytically reacting a 7(9)- arene tetracycline diazonium salt or an iodotetracycline and a reactive substituent precursor, e.g., (substituted) alkenes, vinyl monomers, aromatics, carbon monoxide; carboxylation, esterification, amidation carbonylation, cyanation; anhydriding; imidation; bactericides
01/31/2012US8106213 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
01/31/2012US8106041 Combination product comprising an antagonist or inverse agonist of histamine receptor H3 and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs
01/26/2012WO2011118818A8 Amidinoaniline derivative
01/26/2012US20120022263 3-aminoxalyl-aminobenzamide derivatives and insecticidal and miticidal agents containing same as active ingredient
01/26/2012US20120022080 Plasminogen Activator Inhibitor-1 Inhibitor
01/26/2012US20120022070 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use
01/26/2012US20120022042 Carbocyclic glyt1 receptor antagonists
01/25/2012EP2408742A1 Anthelmintic agents and their use
01/25/2012EP1831149B1 Novel ligands that modulate rar receptors and use thereof in human medicine and in cosmetics
01/25/2012EP1781631B1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
01/25/2012EP1765778B1 N-sulfonylcarboximidamide apoptosis promoters
01/25/2012CN102333757A N-acyl anthranilic acid derivative or salt thereof
01/24/2012US8101750 Process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile 701
01/24/2012US8101640 Antibacterial agents
01/24/2012US8101609 Processes for the preparation of rivaroxaban and intermediates thereof
01/24/2012US8101591 9-aminoacyl tetracycline compounds and methods of use thereof
01/24/2012CA2511582C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
01/24/2012CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
01/24/2012CA2394327C Substituted piperazine and piperidine calcium channel blockers
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 341